Stock screener

EOLS

Conviction 72HealthcareScan · Thu, Jun 25, 2026
EOLS$7.15+2.58%
ResistanceSupportVol 14
63 bars
Vol MA14 757.48K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Evolus, Inc.PHARMACEUTICAL PREPARATIONSwww.evolus.com
Price7.15
Change+2.58%
Gap-0.43%
Rel volume1.41×
Avg volume774.25K
Avg $ vol5.15M
SMA 206.63
SMA 506.14
SMA 2005.89
Price vs 50+16.48%
Price vs 200+21.33%
MA stackbullish
50/200 crossgolden · 4d
Supertrendup · 6.03
RSI (14)66
MACD hist0.01
MACD crossbull · 0d
Stoch %K / %D100 / 86
ADX (14)31
+DI / −DI27 / 13
RSI divergenceBearish
MACD divergence
ATR %+4.60%
ADR %4.99%
52w high9.73
52w low3.94
From 52w high-26.52%
Above 52w low+81.47%
New 52w highNo
SqueezeOn · 10d
Bollinger width13.89%
%B1.06
Donchian pos100.00%
Donchian high7.15
Donchian low5.95
AVWAP (52w high)6.24
vs AVWAP high+14.50%
AVWAP (52w low)5.83
vs AVWAP low+22.66%
OBV trendUp
Chaikin MF (20)-0.03
Today vs 20d1.41×
Avg vol (14d)757.48K
Avg vol (20d)774.25K
Avg $ vol (20d)5.15M
Market cap470.86M
RS 3m (vs SPY)+45.08%
RS 6m (vs SPY)-9.15%
RS line new highYes
Trend template4/8
Technical rank79.4
1 week+6.08%
1 month+14.40%
3 months+63.62%
6 months-0.56%
1 year-25.68%
YTD+6.40%
P/E-9.12
P/B-16.36
P/S1.58
P/FCF-10.30
EPS-0.8000
Div yield
ROE179.43%
ROA-23.40%
Debt/Eq-5.43
Current2.04
EV/EBITDA-22.96
Gross margin66.33%
Net margin-17.38%
Rev growth11.61%
EPS growth-2.42%
Price target14.50
Target upside102.80%
Analyst ratingBuy
Institutional74.55%
Ent. value577.48M
Revenue73.14M
Net income-10.67M
Gross profit48.9M
Free cash flow-45.71M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out65.85M
Employees350
ListedThu, Feb 8, 2018
Free float52.47M
Float %79.7%
Short interest6.06M
Days to cover8.2d
Short volume46.6%
Squeeze score59 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.09 · 2 est
Last EPS vs est−$0.16 vs −$0.22
Last surprise+27.3% beat
Setup gradeB
Conviction72 / 100
Pattern quality
Tech rank79.4 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance6.97
Support5.98
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EOLS

All disclosures →
No recent disclosed trades by Congress in EOLS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EOLS

No recent insider (Form 4) filings in EOLS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in EOLS · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.